Microchip at Bank of America Global Tech: Strategic Inventory Moves

During Microchip Technology's participation in the Bank of America Global Technology Conference 2025, CFO Eric Bjornhardt conveyed optimism regarding the semiconductor industry's rebound, noting May bookings hit a two-year high, driven by inventory replenishment across all markets and regions. The company is focused on reducing inventory by $350 million this fiscal year and managing tariff impacts, which affect 14% of revenue, through supply chain flexibility. While inventory write-offs and underutilization charges have impacted gross margins, the underlying product gross margins were nearly 67% in March when adjusted, and the company aims to maintain its dividend while reducing leverage, targeting a net leverage of 1.5 times.

Analysis

Microchip Technology (MCHP), as detailed by CFO Eric Bjornhardt at the Bank of America Global Technology Conference 2025, is navigating a semiconductor industry rebound with a strategic focus on inventory management and operational efficiency. May bookings hit a two-year high, primarily driven by broad-based inventory replenishment, signaling recovery from a recent revenue low of $970.4 million last quarter, a significant drop from its peak of nearly $2.3 billion per quarter. The company is targeting a $350 million inventory reduction this fiscal year, which is crucial as substantial inventory write-offs (over $90 million in the March quarter) and underutilization charges ($54 million in March) have suppressed reported gross margins. However, adjusted underlying product gross margins stood at nearly 67% in March, aligning with the non-GAAP gross margin target of 65%, and the company projects gross margins to exceed 60% by fiscal year-end. Approximately 14% of revenue is exposed to potential tariff impacts, but Microchip plans to mitigate this through supply chain flexibility, including shifting manufacturing. Financially, the company recently borrowed $300 million to support its commitment to maintaining the dividend, while prioritizing deleveraging towards a 1.5 times net leverage target; consequently, stock buybacks are not a near-term focus. Operational expenses are guided to a low point of $356 million, and factory utilization is expected to increase by September, supporting the recovery narrative.

Key Decisions for Investors

• Investors should closely monitor Microchip's progress in reducing its inventory levels and the consequent impact of diminishing write-off and underutilization charges on achieving its gross margin targets of over 60% by fiscal year-end and a non-GAAP target of 65%.
• Consider the ongoing inventory replenishment cycle as the primary catalyst for near-term revenue recovery from the recent $970.4 million quarterly low, while simultaneously assessing the company's execution on operational expense control and debt reduction towards its 1.5x net leverage target.
• Acknowledge Microchip's commitment to maintaining its dividend, which is currently supported by recent financing, but recognize that substantial deleveraging efforts will likely take precedence over the resumption of stock buyback programs.
• Evaluate the potential financial implications of tariffs on the 14% of exposed revenue and the effectiveness of Microchip's stated mitigation strategies, such as shifting production to alternative foundry locations like Taiwan.